We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus.
- Authors
Sun, Bo-Wen; Zhang, Peng-Peng; Wang, Zong-Hao; Yao, Xia; He, Meng-Lan; Bai, Rui-Ting; Che, Hao; Lin, Jing; Xie, Tian; Hui, Zi; Ye, Xiang-Yang; Wang, Li-Wei
- Abstract
Respiratory syncytial virus (RSV) is a significant viral pathogen that causes respiratory infections in infants, the elderly, and immunocompromised individuals. RSV-related illnesses impose a substantial economic burden worldwide annually. The molecular structure, function, and in vivo interaction mechanisms of RSV have received more comprehensive attention in recent times, and significant progress has been made in developing inhibitors targeting various stages of the RSV replication cycle. These include fusion inhibitors, RSV polymerase inhibitors, and nucleoprotein inhibitors, as well as FDA-approved RSV prophylactic drugs palivizumab and nirsevimab. The research community is hopeful that these developments might provide easier access to knowledge and might spark new ideas for research programs.
- Subjects
RESPIRATORY syncytial virus; UNITED States. Food &; Drug Administration; INFANTS; PALIVIZUMAB; MOLECULAR structure; RESPIRATORY infections; IMMUNOCOMPROMISED patients; NITROGEN cycle
- Publication
Molecules, 2024, Vol 29, Issue 3, p598
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules29030598